02:01 AM EDT, 10/07/2026 (MT Newswires) -- Sensorion (ALSEN.PA) appointed Lou Arcudi as its new chief financial officer to succeed Laurene Danon, who stepped down to pursue external opportunities. Arcudi, whose appointment takes effect on Wednesday, most recently served as CFO at French clinical-stage biotechnology company Amolyt Pharma, according to a same-day release.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.